- call +1-201-465-4211
- email sales@mrinsights.biz
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Scope of the Report:
Increasing research and development expenditure on biologic drugs is expected to boost demand for recombinant proteins for research purposes
The global Recombinant Proteins market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Recombinant Proteins.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Recombinant Proteins market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Recombinant Proteins market by product type and applications/end industries.
Market Segment by Companies, this report covers
Crown Bioscience, Inc
ProSpec Tany TechnoGene, Ltd.
BPS Bioscience, Inc.
Sigma Aldrich Company Ltd.
Novoprotein Scientific
PeproTech, Inc.
Feldan Bio, Inc.
BioVision, Inc.
HumanZyme, Inc.
GenScript Biotech Corporation
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Market Segment by Applications, can be divided into
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Recombinant Proteins Market Overview
1.1 Product Overview and Scope of Recombinant Proteins
1.2 Classification of Recombinant Proteins by Types
1.2.1 Global Recombinant Proteins Revenue Comparison by Types (2017-2023)
1.2.2 Global Recombinant Proteins Revenue Market Share by Types in 2017
1.2.3 Hormones
1.2.4 Growth Factors
1.2.5 Cytokines
1.2.6 Plasma Protein Factor
1.2.7 Recombinant Metabolic Enzymes
1.2.8 Immune Checkpoint Regulators
1.2.9 Others
1.3 Global Recombinant Proteins Market by Application
1.3.1 Global Recombinant Proteins Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.3.4 Contract Research Organizations
1.3.5 Others
1.4 Global Recombinant Proteins Market by Regions
1.4.1 Global Recombinant Proteins Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Recombinant Proteins Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Recombinant Proteins Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Recombinant Proteins Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Recombinant Proteins Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Recombinant Proteins Status and Prospect (2013-2023)
1.5 Global Market Size of Recombinant Proteins (2013-2023)
2 Manufacturers Profiles
2.1 Crown Bioscience, Inc
2.1.1 Business Overview
2.1.2 Recombinant Proteins Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Crown Bioscience, Inc Recombinant Proteins Revenue, Gross Margin and Market Share (2016-2017)
2.2 ProSpec Tany TechnoGene, Ltd.
2.2.1 Business Overview
2.2.2 Recombinant Proteins Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 ProSpec Tany TechnoGene, Ltd. Recombinant Proteins Revenue, Gross Margin and Market Share (2016-2017)
2.3 BPS Bioscience, Inc.
2.3.1 Business Overview
2.3.2 Recombinant Proteins Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BPS Bioscience, Inc. Recombinant Proteins Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sigma Aldrich Company Ltd.
2.4.1 Business Overview
2.4.2 Recombinant Proteins Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sigma Aldrich Company Ltd. Recombinant Proteins Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novoprotein Scientific
2.5.1 Business Overview
2.5.2 Recombinant Proteins Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novoprotein Scientific Recombinant Proteins Revenue, Gross Margin and Market Share (2016-2017)
2.6 PeproTech, Inc.
2.6.1 Business Overview
2.6.2 Recombinant Proteins Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 PeproTech, Inc. Recombinant Proteins Revenue, Gross Margin and Market Share (2016-2017)
2.7 Feldan Bio, Inc.
2.7.1 Business Overview
2.7.2 Recombinant Proteins Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Feldan Bio, Inc. Recombinant Proteins Revenue, Gross Margin and Market Share (2016-2017)
2.8 BioVision, Inc.
2.8.1 Business Overview
2.8.2 Recombinant Proteins Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 BioVision, Inc. Recombinant Proteins Revenue, Gross Margin and Market Share (2016-2017)
2.9 HumanZyme, Inc.
2.9.1 Business Overview
2.9.2 Recombinant Proteins Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 HumanZyme, Inc. Recombinant Proteins Revenue, Gross Margin and Market Share (2016-2017)
2.10 GenScript Biotech Corporation
2.10.1 Business Overview
2.10.2 Recombinant Proteins Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 GenScript Biotech Corporation Recombinant Proteins Revenue, Gross Margin and Market Share (2016-2017)
3 Global Recombinant Proteins Market Competition, by Players
3.1 Global Recombinant Proteins Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Recombinant Proteins Players Market Share
3.2.2 Top 10 Recombinant Proteins Players Market Share
3.3 Market Competition Trend
4 Global Recombinant Proteins Market Size by Regions
4.1 Global Recombinant Proteins Revenue and Market Share by Regions
4.2 North America Recombinant Proteins Revenue and Growth Rate (2013-2018)
4.3 Europe Recombinant Proteins Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Recombinant Proteins Revenue and Growth Rate (2013-2018)
4.5 South America Recombinant Proteins Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Recombinant Proteins Revenue and Growth Rate (2013-2018)
5 North America Recombinant Proteins Revenue by Countries
5.1 North America Recombinant Proteins Revenue by Countries (2013-2018)
5.2 USA Recombinant Proteins Revenue and Growth Rate (2013-2018)
5.3 Canada Recombinant Proteins Revenue and Growth Rate (2013-2018)
5.4 Mexico Recombinant Proteins Revenue and Growth Rate (2013-2018)
6 Europe Recombinant Proteins Revenue by Countries
6.1 Europe Recombinant Proteins Revenue by Countries (2013-2018)
6.2 Germany Recombinant Proteins Revenue and Growth Rate (2013-2018)
6.3 UK Recombinant Proteins Revenue and Growth Rate (2013-2018)
6.4 France Recombinant Proteins Revenue and Growth Rate (2013-2018)
6.5 Russia Recombinant Proteins Revenue and Growth Rate (2013-2018)
6.6 Italy Recombinant Proteins Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Recombinant Proteins Revenue by Countries
7.1 Asia-Pacific Recombinant Proteins Revenue by Countries (2013-2018)
7.2 China Recombinant Proteins Revenue and Growth Rate (2013-2018)
7.3 Japan Recombinant Proteins Revenue and Growth Rate (2013-2018)
7.4 Korea Recombinant Proteins Revenue and Growth Rate (2013-2018)
7.5 India Recombinant Proteins Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Recombinant Proteins Revenue and Growth Rate (2013-2018)
8 South America Recombinant Proteins Revenue by Countries
8.1 South America Recombinant Proteins Revenue by Countries (2013-2018)
8.2 Brazil Recombinant Proteins Revenue and Growth Rate (2013-2018)
8.3 Argentina Recombinant Proteins Revenue and Growth Rate (2013-2018)
8.4 Colombia Recombinant Proteins Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Recombinant Proteins by Countries
9.1 Middle East and Africa Recombinant Proteins Revenue by Countries (2013-2018)
9.2 Saudi Arabia Recombinant Proteins Revenue and Growth Rate (2013-2018)
9.3 UAE Recombinant Proteins Revenue and Growth Rate (2013-2018)
9.4 Egypt Recombinant Proteins Revenue and Growth Rate (2013-2018)
9.5 Nigeria Recombinant Proteins Revenue and Growth Rate (2013-2018)
9.6 South Africa Recombinant Proteins Revenue and Growth Rate (2013-2018)
10 Global Recombinant Proteins Market Segment by Type
10.1 Global Recombinant Proteins Revenue and Market Share by Type (2013-2018)
10.2 Global Recombinant Proteins Market Forecast by Type (2018-2023)
10.3 Hormones Revenue Growth Rate (2013-2023)
10.4 Growth Factors Revenue Growth Rate (2013-2023)
10.5 Cytokines Revenue Growth Rate (2013-2023)
10.6 Plasma Protein Factor Revenue Growth Rate (2013-2023)
10.7 Recombinant Metabolic Enzymes Revenue Growth Rate (2013-2023)
10.8 Immune Checkpoint Regulators Revenue Growth Rate (2013-2023)
10.9 Others Revenue Growth Rate (2013-2023)
11 Global Recombinant Proteins Market Segment by Application
11.1 Global Recombinant Proteins Revenue Market Share by Application (2013-2018)
11.2 Recombinant Proteins Market Forecast by Application (2018-2023)
11.3 Biopharmaceutical Companies Revenue Growth (2013-2018)
11.4 Academic and Research Institutes Revenue Growth (2013-2018)
11.5 Contract Research Organizations Revenue Growth (2013-2018)
11.6 Others Revenue Growth (2013-2018)
12 Global Recombinant Proteins Market Size Forecast (2018-2023)
12.1 Global Recombinant Proteins Market Size Forecast (2018-2023)
12.2 Global Recombinant Proteins Market Forecast by Regions (2018-2023)
12.3 North America Recombinant Proteins Revenue Market Forecast (2018-2023)
12.4 Europe Recombinant Proteins Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Recombinant Proteins Revenue Market Forecast (2018-2023)
12.6 South America Recombinant Proteins Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Recombinant Proteins Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Recombinant Proteins Picture
Table Product Specifications of Recombinant Proteins
Table Global Recombinant Proteins and Revenue (Million USD) Market Split by Product
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
